Literature DB >> 1827976

Immunosorbent for selective removal of lipoprotein (a) from human plasma: in vitro study.

S N Pokrovsky1, O Y Afanasieva, G F Benevolenskaya.   

Abstract

Sheep polyclonal anti-lipoprotein (a) [anti-Lp(a)] antibodies were used for immunosorbent preparation. The ability of the selective removal of Lp(a) from human plasma by this sorbent was demonstrated in an in vitro study. The material desorbated from the anti-Lp(a) column by acid pH has immunochemical properties identical to those of Lp(a) isolated by ordinary methods. The binding capacity of anti-Lp(a) sorbent is 3 mg Lp(a) per 1 ml gel. Immunosorbent prepared in this study was reusable. It is suggested that anti-Lp(a) immunosorbent may be applied for clinical plasma adsorption therapy for the Lp(a)-apheresis procedure, especially for patients with high Lp(a) concentration in blood and with stenosis in coronary and cerebral arteries.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1827976     DOI: 10.1111/j.1525-1594.1991.tb00771.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  3 in total

1.  Modification of lipoprotein(a) by natural dicarbonyls induced their following free radical peroxidation.

Authors:  V Z Lankin; O I Afanasieva; G G Konovalova; E A Utkina; O A Dmitrieva; A K Tikhaze; E M Kumskova; S N Pokrovsky
Journal:  Dokl Biochem Biophys       Date:  2012-01-06       Impact factor: 0.788

Review 2.  Lipoprotein apheresis to treat elevated lipoprotein (a).

Authors:  Elisa Waldmann; Klaus G Parhofer
Journal:  J Lipid Res       Date:  2016-02-17       Impact factor: 5.922

Review 3.  LDL-apheresis: technical and clinical aspects.

Authors:  Rolf Bambauer; Carolin Bambauer; Boris Lehmann; Reinhard Latza; Ralf Schiel
Journal:  ScientificWorldJournal       Date:  2012-04-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.